--- title: "Legend Biotech Corporation Stock 12‑Month Price Target Raised to $57.53, Implies 106% Upside" type: "News" locale: "en" url: "https://longbridge.com/en/news/290317939.md" description: "Legend Biotech Corporation's 12-month average price target has been raised to $57.53 by 15 analysts, up from $56.63. Based on the June 18 closing price, this implies a 106% upside potential. The consensus rating remains 'Buy', with 13 analysts recommending Buy, 2 Holds, and 0 Sells." datetime: "2026-06-20T04:20:04.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/290317939.md) - [en](https://longbridge.com/en/news/290317939.md) - [zh-HK](https://longbridge.com/zh-HK/news/290317939.md) generator: "portal-rs" --- # Legend Biotech Corporation Stock 12‑Month Price Target Raised to $57.53, Implies 106% Upside - According to estimates from 15 analysts, Legend Biotech Corporation stock's average price target has risen from $56.63 to $57.53, with forecasts ranging from $27 to $86 per share - Based on the Jun. 18 closing price, the updated target implies approximately 106% potential upside - Consensus rating remains at “Buy” across 15 covering analysts, with 13 Buys, 2 Holds and 0 Sells Explore more price target data and ratings for Legend Biotech Corporation on the , and track all previous and future analyst recommendations for Legend Biotech Corporation in the dedicated News Flow. **Disclaimer** Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice. ### Related Stocks - [LEGN.US](https://longbridge.com/en/quote/LEGN.US.md) ## Related News & Research - [TD Cowen Sticks to Its Hold Rating for Legend Biotech (LEGN)](https://longbridge.com/en/news/295580007.md) - [GenScript Biotech announces Legend Biotech Form 6-K for Q2 ended June 30, 2026](https://longbridge.com/en/news/295534476.md) - [Ross Stores To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Friday](https://longbridge.com/en/news/296618142.md) - [Top Wall Street Forecasters Revamp Advance Auto Parts Expectations Ahead Of Q2 Earnings](https://longbridge.com/en/news/296450286.md) - [Slowing Sales and Margin Uncertainty Lead Max Rakhlenko to Maintain Hold on AAP](https://longbridge.com/en/news/296540280.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**